This week, both USANA Heath Sciences and LifeVantage Corp. participated in the 26th annual ROTH Conference presented by ROTH Capital Partners, an investment banking firm focused on small-cap public companies. The firm’s prominent investor conferences showcase emerging growth companies across a variety of sectors.
Chief Financial Officer Paul Jones presented for USANA. The wellness company closed out its 11th consecutive year of record sales in 2013 with a 10.5 percent net sales increase in the fourth quarter. Sales totaled $718.2 million in 2013, up 10.7 percent over the prior year. The company’s earnings per share climbed to a record $5.56 for 2013.
President and CEO Douglas C. Robinson presented for LifeVantage, a marketer of science-based products promoting healthy living. In February, LifeVantage reported its second quarter fiscal 2014 results. Net revenue totaled $51.5 million, compared to $53.4 million for the same period in 2013. Though foreign currency fluctuation negatively impacted total revenue by 6.7 percent, the company saw revenue in the Americas increase 7.2 percent compared to the prior year. This week, LifeVantage’s board of directors authorized a $3 million share repurchase program, with an additional $3 million to accelerate the company’s debt pay down.